Biotech News
GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older
gsk.com2026-05-06 14:36 EST
An approval from the US Food and Drug Administration’s (FDA) Center
Full article
Biotech News
An approval from the US Food and Drug Administration’s (FDA) Center